Removing Racial Inequalities in Lab Referrals
Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities
Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
From - Diagnostic Testing & Emerging Technologies
The notion of empowering patients to take control over their own health care is particularly powerful within the realm of…
By Robert Liles bio
Over the last year, a number of genetic testing fraud investigations and prosecutions have been initiated by…
From - Diagnostic Testing & Emerging Technologies
The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for…